ERBB2 and neoplasm: Ricciardelli et al. [21] reported that high levels of both tumour ErbB2-IR and AR-IR were more common in Pca patients with stage 3 tumours (n = 31) than in stage 2 tumours (n = 22, samples obtained at radical prostatectomy).